Your Search for 'The Executive Guide to Molecular Imaging' returned 44 results - Page 1 of 3

• Molecular Diagnostics - Technologies, Markets and Companies

  EURO€ 4,228.00USD$ 5,500.00GBP£ 3,557.00AUD$ 5,379.00JPY¥ 543,031.00SEK 36 112,00CHF 5'184.00CAD$ 5,604.00 Jain PharmaBiotech, May 2013 , Pages: 1090
  and biowarfare agents such as anthrax. The number of companies involved in molecular diagnostics has increased remarkably during the past few years. More than 800 companies have been identified to be ...

• Innovations in Medical Imaging: Technological Advances, Growth Opportunities and Future Market Outlook

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Aug 2009 , Pages: 152
  , molecular imaging and new imaging agents will expand the use of medical imaging in a broad range of disease and medical settings to ensure patients receive the right technology to get the right treatment ...

• Biomarkers - Technologies, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 920
  biomarkers in drug development in oncology Molecular imaging of tumor as a guide to drug development Use of PET to assess response to anticancer drugs Use of MRI to assess response to anticancer drugs ...

• Nanobiotechnology Applications, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 771
  chapter along with their 183 collaborations.The report is supplemented with 41 Tables, 24 figures and 800 references to the literature. Part I: Applications & Markets Executive Summary 1. Introduction ...

• Personalized Medicine - Scientific and Commercial Aspects

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 854
  relevant to personalized medicine Molecular biological basis of personalized medicine The human genome ENCODE Chromosomes Genes The genetic code Gene expression DNA sequences and structure Genetic ...

• Innovations in Oncology Diagnostics: Technological Advances, Growth Opportunities and Future Market Outlook

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Oct 2009 , Pages: 141
  key areas of innovation in the diagnostics markets, use this to help guide company strategy. Key findings from this report Molecular diagnostics and biomarkers are the key drivers of the oncology ...

• Analysis of the U.S. Breast Imaging Systems Market

  EURO€ 4,612.00USD$ 6,000.00GBP£ 3,880.00AUD$ 5,868.00JPY¥ 592,398.00SEK 39 395,00CHF 5'655.00CAD$ 6,114.00 Frost & Sullivan, Jan 2013 , Pages: 168
  Analysis of the U.S. Breast Imaging Systems Market A Guide to One of Medical Imaging's Key Multi-modality Hubs This research service evaluates the U.S. breast imaging systems market during the 2008 ...

• The Future of Cardiovascular Diagnostics: Impact of Technological Advances on Growth Opportunities and Future Market Outlook

  EURO€ 2,948.00USD$ 3,835.00GBP£ 2,480.00AUD$ 3,751.00JPY¥ 378,641.00SEK 25 180,00CHF 3'615.00CAD$ 3,908.00 Scripp Business Insights, Mar 2010 , Pages: 180
  to stratify high risk patients whilst the advances in diagnostic imaging has lead to improvements in the speed and resolution of images, increasing its clinical utility in the detection, diagnosis and ...

• Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine

  EURO€ 2,525.00USD$ 3,285.00GBP£ 2,124.00AUD$ 3,213.00JPY¥ 324,338.00SEK 21 569,00CHF 3'096.00CAD$ 3,347.00 JZMed Inc, Jan 2011 , Pages: 282
  leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and ...

• Refurbished Medical Equipments Market - By Device Types & Applications (2012-2017) - Global Trends & Competitive Analysis

  EURO€ 3,574.00USD$ 4,650.00GBP£ 3,007.00AUD$ 4,548.00JPY¥ 459,108.00SEK 30 531,00CHF 4'383.00CAD$ 4,738.00 Markets and Markets, Aug 2012 , Pages: 314
  %. Biotechnology instruments and imaging-monitoring-diagnostic devices contribute to the maximum share (78%) to the global refurbished devices market, followed by minimally invasive surgical devices (16%) and ...

• Alzheimer Disease - New Drugs, Markets and Companies

  EURO€ 2,690.00USD$ 3,500.00GBP£ 2,263.00AUD$ 3,423.00JPY¥ 345,565.00SEK 22 980,00CHF 3'299.00CAD$ 3,566.00 Jain PharmaBiotech, May 2013 , Pages: 550
  associated with AD Retinal imaging to detect Aß deposits Laboratory methods for diagnosis of AD Monitoring of synthesis and clearance rates of Aß in the CSF Molecular diagnostics for AD Genetic tests for ...

• Nuclear Cardiology Markets

  EURO€ 2,613.00USD$ 3,400.00GBP£ 2,199.00AUD$ 3,325.00JPY¥ 335,692.00SEK 22 324,00CHF 3'205.00CAD$ 3,465.00 TriMark Publications, May 2011 , Pages: 252
  equipment is mainly driven by the number of diagnostic procedures. The application of PET's clinical use, its combined use with other imaging equipment and the current shift to PET/CT imaging and SPECT/CT ...

• Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

  EURO€ 1,533.00USD$ 1,995.00GBP£ 1,290.00AUD$ 1,951.00JPY¥ 196,972.00SEK 13 099,00CHF 1'880.00CAD$ 2,033.00 Life Science Intelligence, Dec 2011 , Pages: 605
  device - Unique, patented, activated collagen, CellerateRX(R) for the expanding diabetes and greater wound care markets - Ultrasound-based molecular imaging agents that can be used to: 1-diagnose and ...

• 2011 Emerging Medical Technologies Spotlight: A Report of Investment & Partnering Opportunities

  EURO€ 1,533.00USD$ 1,995.00GBP£ 1,290.00AUD$ 1,951.00JPY¥ 196,972.00SEK 13 099,00CHF 1'880.00CAD$ 2,033.00 Life Science Intelligence, Dec 2011 , Pages: 605
  - Ultrasound-based molecular imaging agents that can be used to: 1-diagnose and stage disease, 2-monitor response to therapy in the pharmaceutical research setting, and 3-elucidate the biology of disease ...

• Proteomics - Technologies, Markets and Companies

  EURO€ 3,843.00USD$ 5,000.00GBP£ 3,233.00AUD$ 4,890.00JPY¥ 493,665.00SEK 32 829,00CHF 4'713.00CAD$ 5,095.00 Jain PharmaBiotech, May 2013 , Pages: 631
  Proteomics - Technologies, Markets and Companies This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice ...

• Pain Therapeutics - Drugs, Markets and Companies

  EURO€ 3,075.00USD$ 4,000.00GBP£ 2,587.00AUD$ 3,912.00JPY¥ 394,932.00SEK 26 263,00CHF 3'770.00CAD$ 4,076.00 Jain PharmaBiotech, May 2013 , Pages: 544
  markets for analgesic drugs. The report is supplemented with 67 tables, 18 figures, and 600 selected references to the literature. Executive Summary 1. Basic Aspects of Pain Introduction Historical ...

• Cell Therapy - Technologies, Markets and Companies

  EURO€ 4,228.00USD$ 5,500.00GBP£ 3,557.00AUD$ 5,379.00JPY¥ 543,031.00SEK 36 112,00CHF 5'184.00CAD$ 5,604.00 Jain PharmaBiotech, May 2013 , Pages: 1050
  aging Stem cells in space Study of the molecular mechanism of cell differentiation Switch of stem-cell function from activators to repressors Stem cell research at academic centers International ...

• Cardiovascular Drug Delivery - Technologies, Markets and Companies

  EURO€ 2,152.00USD$ 2,800.00GBP£ 1,811.00AUD$ 2,739.00JPY¥ 276,452.00SEK 18 384,00CHF 2'639.00CAD$ 2,853.00 Jain PharmaBiotech, May 2013 , Pages: 265
  addition to the usual formulations of drugs such as controlled release, devices are used as well. This report starts with an introduction to molecular cardiology and discusses its relationship to ...

• The Neurotechnology Industry 2012 Report

  EURO€ 3,459.00USD$ 4,500.00GBP£ 2,910.00AUD$ 4,401.00JPY¥ 444,298.00SEK 29 546,00CHF 4'241.00CAD$ 4,585.00 NeuroInsights, Aug 2012
  The Neurotechnology Industry 2012 Report Drugs, Biologics, Stem Cells, Devices and Diagnostics for the Brain and Nervous System: Market Analysis and Strategic Investment Guide of the Global ...

• Emerging Medical Technologies Spotlight

  EURO€ 2,302.00USD$ 2,995.00GBP£ 1,937.00AUD$ 2,929.00JPY¥ 295,705.00SEK 19 665,00CHF 2'823.00CAD$ 3,052.00 Life Science Intelligence, May 2013
  breakthrough pain, and migraines - Company 188 - The Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI/MBI - a molecular breast imaging procedure which images the ...